RxDoctor Payments DataLook up a doctor →

Mimi van der Leden

Family Medicine · Spring, TXNPI 1932166741

Payments from drug & device makers

$2,565,956in general payments, 2019–2025

Across 10,726 payments — averaging $239.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$1.4M
  • Pfizer$550K
  • Janssen Research & Development, LLC$381K
  • Sanofi Pasteur Inc.$177K
  • Eli Lilly$19K
  • Alnylam Pharmaceuticals Inc.$19K
  • plus $11K from 1 others
$1,722in research payments, 2019–2025

Across 1 payment — averaging $1722.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Modernatx, Inc.10,560$1,409,104
Pfizer10$550,246
Janssen Research & Development, LLC4$380,928
Sanofi Pasteur Inc.6$177,226
Eli Lilly1$19,450
Alnylam Pharmaceuticals Inc.144$18,502
Merck1$10,500

How this compares

$2,565,956 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Other family medicine in Spring

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →